Acuson and Advanced Technology Laboratories last week settleda patent dispute between the ultrasound competitors relating tomultiplane transesophageal (TEE) technology and an ultrasoundfocusing technique. The settlement ends lawsuits that had beenfiled
Acuson and Advanced Technology Laboratories last week settleda patent dispute between the ultrasound competitors relating tomultiplane transesophageal (TEE) technology and an ultrasoundfocusing technique. The settlement ends lawsuits that had beenfiled last year in federal courts in Washington and California.
ATL had claimed that Acuson was infringing on its TEE patents,while Acuson charged ATL will violating its patent for an ultrasoniclens with reduced delay range. As part of the settlement, Acusonagreed to pay ATL an undisclosed sum in royalty payments on TEEprobes it sells. The companies entered a cross-licensing agreementfor several patents, including the Acuson focusing patent.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.